University Of Texas/texas Am Investment Managment as of Sept. 30, 2018
Portfolio Holdings for University Of Texas/texas Am Investment Managment
University Of Texas/texas Am Investment Managment holds 20 positions in its portfolio as reported in the September 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spdr S&p 500 Etf (SPY) | 73.4 | $59M | 204k | 290.72 | |
Texas Instruments Incorporated (TXN) | 4.3 | $3.5M | 33k | 107.29 | |
Vanguard Europe Pacific ETF (VEA) | 4.1 | $3.3M | 77k | 43.27 | |
Aeglea Biotherapeutics | 4.0 | $3.2M | 335k | 9.57 | |
Vanguard S&p 500 Etf idx (VOO) | 3.7 | $3.0M | 11k | 267.03 | |
Vanguard Mid-Cap Value ETF (VOE) | 3.6 | $2.9M | 26k | 113.07 | |
Vanguard Emerging Markets ETF (VWO) | 3.1 | $2.5M | 61k | 40.99 | |
Vanguard Energy ETF (VDE) | 1.3 | $1.1M | 10k | 105.07 | |
Vanguard REIT ETF (VNQ) | 1.1 | $859k | 11k | 80.67 | |
Lexicon Pharmaceuticals (LXRX) | 0.5 | $381k | 36k | 10.67 | |
Plx Pharma | 0.3 | $254k | 63k | 4.05 | |
Bio Path Holdings | 0.3 | $226k | 383k | 0.59 | |
Apollo Endosurgery | 0.1 | $112k | 16k | 7.18 | |
Exxon Mobil Corporation (XOM) | 0.1 | $50k | 583.00 | 85.76 | |
United Therapeutics Corporation (UTHR) | 0.1 | $40k | 315.00 | 126.98 | |
Abbott Laboratories (ABT) | 0.0 | $25k | 343.00 | 72.89 | |
Abbvie (ABBV) | 0.0 | $25k | 263.00 | 95.06 | |
Huntington Bancshares Incorporated (HBAN) | 0.0 | $5.0k | 335.00 | 14.93 | |
Portland General Electric Company (POR) | 0.0 | $5.0k | 118.00 | 42.37 | |
Regions Financial Corporation (RF) | 0.0 | $5.0k | 270.00 | 18.52 |